Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4CJA
|
||||
| Drug Name |
benzyl (S)-1-((R)-2-(benzyloxy)-1-cyanoethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL206006
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H29N3O4
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](COCc2ccccc2)C#N
|
||||
| InChI |
InChI=1S/C24H29N3O4/c1-18(2)13-22(27-24(29)31-16-20-11-7-4-8-12-20)23(28)26-21(14-25)17-30-15-19-9-5-3-6-10-19/h3-12,18,21-22H,13,15-17H2,1-2H3,(H,26,28)(H,27,29)/t21-,22+/m1/s1
|
||||
| InChIKey |
BMFYRFFIWZYPGT-YADHBBJMSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.